Sheehan Syndrome: Postpartum Pituitary Necrosis, Lactation Failure Clue, and Lifelong Hormone Replacement
A comprehensive guideline to recognizing postpartum hypopituitarism through the earliest lactation failure clue, distinguishing from pituitary apoplexy and lymphocytic hypophysitis, and navigating the lifelong multi-axis hormone replacement strategy.
Executive Summary
Sheehan syndrome is anterior pituitary hypofunction resulting from ischemic necrosis of the gestationally hypertrophied anterior pituitary following obstetric hemorrhage with hemodynamic compromise. The pathogenesis combines the gestational pituitary enlargement (30-100 percent due to lactotroph hyperplasia) outstripping its arterial supply, with postpartum hemorrhagic hypotension producing ischemic injury to the vulnerable gland. The posterior pituitary is typically spared because of its separate arterial blood supply, distinguishing Sheehan from pituitary apoplexy where diabetes insipidus may occur. The earliest and most specific clinical clue is lactation failure in a postpartum mother who experienced significant hemorrhage; subsequent insidious development of amenorrhea, fatigue, weight loss, cold intolerance, and hypotension reflects progressive multi-axis deficits. Diagnosis combines clinical suspicion with biochemical confirmation of anterior pituitary hormone deficiencies (cortisol, TSH/free T4, prolactin, LH/FSH/estradiol, IGF-1) and characteristic MRI empty sella in chronic disease. Treatment is lifelong individualized hormone replacement: hydrocortisone 10-15 mg AM + 5 mg PM, levothyroxine 1.6 mcg/kg/day, cyclic estrogen-progesterone in premenopausal women, and growth hormone in selected patients. Cortisol MUST be replaced BEFORE levothyroxine to avoid precipitating adrenal crisis.
Table of Contents
- Pathophysiology and Risk Factors for Pituitary Necrosis
- Clinical Presentation and the Lactation Failure Clue
- Diagnostic Workup: Hormone Panel and MRI Empty Sella
- Differential: Pituitary Apoplexy, Lymphocytic Hypophysitis, Empty Sella Syndrome
- Lifelong Multi-Axis Hormone Replacement Strategy
- Practice Insights — Lessons from the Endocrinology Clinic
- Frequently Asked Questions
S1. Pathophysiology and Risk Factors for Pituitary Necrosis
Sheehan syndrome was first described by Harold Sheehan in 1937 based on autopsy series identifying ischemic necrosis of the anterior pituitary in women who died of postpartum hemorrhage. The pathophysiology combines two essential elements creating the vulnerable substrate for ischemic injury during obstetric hemorrhage.
Gestational Pituitary Hypertrophy
The pituitary gland enlarges substantially during normal pregnancy, increasing in size by 30-100 percent (predominantly the anterior lobe) due to lactotroph hyperplasia driving the prolactin production needed to prepare the breasts for lactation. This hypertrophy creates two vulnerabilities:
- Increased metabolic demand: the enlarged gland has higher oxygen and nutrient requirements
- Outgrowth of arterial supply: the superior hypophyseal arteries do not expand proportionally to the gland enlargement, creating a relative ischemic substrate even in normal pregnancy
- Increased compression susceptibility: the enlarged gland within the bony sella is more vulnerable to compression from any source
Postpartum Hemorrhagic Hypotension
Severe postpartum hemorrhage with associated hypotension produces ischemic necrosis of the metabolically vulnerable enlarged anterior pituitary. Specific risk factors:
| Risk Factor | Mechanism |
|---|---|
| Severe postpartum hemorrhage (typically >1000-2000 mL) | Volume-related hypotension; hemorrhagic shock |
| Hypovolemic shock requiring transfusion | Critical hypoperfusion of pituitary |
| DIC during obstetric event | Microvascular thrombosis compounding ischemia |
| Severe preeclampsia / eclampsia | Endothelial dysfunction predisposes to microvascular injury |
| HELLP syndrome | Hemolysis, hepatic dysfunction, microvascular damage |
| Amniotic fluid embolism | DIC + hemorrhagic shock combination |
| Placental abruption | Concealed hemorrhage may be underestimated |
| Uterine atony unresponsive to uterotonics | Prolonged or massive hemorrhage |
| Operative or surgical delivery with hemorrhage | Cesarean section with significant blood loss |
Why the Posterior Pituitary Is Spared
The anterior and posterior pituitary have fundamentally different vascular supplies:
- Anterior pituitary: supplied primarily through the hypophyseal portal system (superior hypophyseal artery → primary capillary plexus in median eminence → portal veins down stalk → secondary capillary plexus in anterior pituitary). This indirect, low-pressure system is highly vulnerable to ischemia during hypotension.
- Posterior pituitary: supplied directly by the inferior hypophyseal artery branching from internal carotid. This direct higher-pressure arterial supply is more resistant to ischemic injury.
This anatomic distinction explains the characteristic clinical pattern of Sheehan syndrome: anterior pituitary deficits (cortisol, TSH, gonadotropins, prolactin, growth hormone) predominate, with posterior pituitary function (ADH, oxytocin) typically preserved. Diabetes insipidus is uncommon in Sheehan syndrome (less than 5-10 percent), distinguishing it from pituitary apoplexy where DI may occur.
Epidemiology
| Epidemiologic Feature | Pattern |
|---|---|
| Historical incidence | Major cause of hypopituitarism in early-mid 20th century; reported prevalence up to 30 percent of women with severe PPH |
| Modern incidence (high-resource settings) | Substantially declined due to improved obstetric hemorrhage management; uncommon but persistent |
| Modern incidence (low-resource settings) | Remains substantial in regions with limited obstetric care; common in some areas (India, parts of Africa, Middle East) |
| Age at obstetric event | Reproductive age (typically 20-40 years) |
| Time to recognition | Often delayed years to decades; one of the most frequently delayed-diagnosis endocrine conditions |
S2. Clinical Presentation and the Lactation Failure Clue
Acute Sheehan Syndrome (Days to Weeks Postpartum)
Severe Sheehan syndrome with extensive pituitary necrosis can present acutely within days to weeks of the obstetric event:
- Adrenal crisis: severe hypotension, hyponatremia, hypoglycemia, altered mental status, shock; may be lethal without prompt recognition and IV hydrocortisone
- Severe hypothyroidism: extreme fatigue, hypothermia, bradycardia, mental status changes (myxedema coma in severe cases)
- Failure to lactate: immediate inability to initiate breastfeeding
- Failure of postpartum menses to resume: amenorrhea from gonadotropin deficiency
- Hyponatremia: cortisol deficiency-mediated; can be severe and life-threatening
Chronic Sheehan Syndrome (Months to Years)
More commonly, Sheehan syndrome develops insidiously over months to years, with diagnosis often delayed by decades. The progressive deficits develop in approximately this order:
| Phase | Hormone Deficits | Clinical Features |
|---|---|---|
| Earliest (first weeks) | Prolactin deficiency; growth hormone deficiency | Lactation failure; nonspecific fatigue often unrecognized |
| Early (weeks-months) | Gonadotropin deficiency (LH, FSH) | Secondary amenorrhea; vasomotor symptoms; vaginal atrophy; reduced libido |
| Intermediate (months-years) | TSH deficiency (central hypothyroidism) | Fatigue, cold intolerance, weight loss (paradoxically vs primary hypothyroid weight gain), dry skin, hair loss, constipation, mild cognitive slowing |
| Late (years-decades) | ACTH deficiency (central adrenal insufficiency) | Profound fatigue, hypotension, orthostatic symptoms, salt craving (less than Addison), hyponatremia, hypoglycemia, weight loss; life-threatening adrenal crisis with stress |
The Lactation Failure Clue
The single highest-yield diagnostic clue is failure to initiate or maintain lactation in a mother who experienced significant obstetric hemorrhage and intended to breastfeed. The mechanism is straightforward: lactotrophs that hypertrophied during pregnancy were the cells most vulnerable to ischemic necrosis, producing prolactin deficiency that manifests immediately as lactation failure.
Despite the diagnostic clarity of this clue, lactation failure is frequently dismissed or attributed to:
- Stress from difficult delivery
- Pain medication interfering with breastfeeding
- Maternal-infant bonding difficulties
- Anxiety or depression
- Inadequate lactation support
The diagnostic shift from these explanations to Sheehan syndrome requires explicit clinician consideration. Any mother who experienced obstetric hemorrhage and cannot lactate despite intent and adequate support deserves anterior pituitary hormone testing including prolactin, TSH, free T4, morning cortisol, and consideration of further workup.
Physical Examination
| Physical Finding | Underlying Deficit |
|---|---|
| Hypotension, orthostatic hypotension | Cortisol deficiency |
| Bradycardia, slow reflex relaxation | Hypothyroidism |
| Cold dry skin, hair loss (including axillary/pubic) | Hypothyroidism + estrogen deficiency |
| Loss of skin pigmentation | Cortisol deficiency (contrast with Addison hyperpigmentation; pale Sheehan) |
| Pale, doughy skin appearance | Multi-axis hypopituitarism gestalt |
| Vaginal atrophy | Estrogen deficiency |
| Breast atrophy | Prolactin and estrogen deficiency |
| Reduced muscle mass | Growth hormone deficiency + chronic hypothyroidism |
| Cognitive slowing, depression | Multi-axis deficits; thyroid and cortisol particularly |
S3. Diagnostic Workup: Hormone Panel and MRI Empty Sella
Anterior Pituitary Hormone Panel
The diagnostic workup centers on confirming anterior pituitary hormone deficiencies through static and dynamic testing.
| Test | Sheehan Pattern | Notes |
|---|---|---|
| Morning serum cortisol | Low (often <5 mcg/dL); ACTH stimulation test if borderline | Most life-threatening deficit; assess urgently |
| ACTH | Inappropriately low or normal for low cortisol | Confirms central (pituitary) adrenal insufficiency, distinguishing from primary (high ACTH) |
| TSH and free T4 | LOW or inappropriately NORMAL TSH with low free T4 | Central hypothyroidism pattern (distinguishes from primary hypothyroidism with HIGH TSH) |
| Prolactin | LOW or undetectable | Hallmark of Sheehan (lactotrophs destroyed); contrast with pituitary tumor causing elevated prolactin |
| LH and FSH | LOW or inappropriately normal | Central hypogonadism (distinguish from primary ovarian failure with high LH/FSH) |
| Estradiol | Low (premenopausal women) | Confirms estrogen deficiency |
| IGF-1 | Low for age | Surrogate for growth hormone deficiency |
| Growth hormone | Variable; pulsatile so single measurement unreliable | GHRH-arginine stimulation test or insulin tolerance test for confirmation |
| Sodium | Hyponatremia (cortisol deficiency mechanism) | May be presenting feature |
| Glucose | Hypoglycemia in severe cases | Cortisol and growth hormone deficiency contributions |
| Hemoglobin | Normocytic anemia | Multifactorial: hypothyroidism, hypogonadism, possibly hypopituitarism-induced |
Dynamic Testing
| Dynamic Test | Indication |
|---|---|
| ACTH (Cosyntropin) stimulation test | Confirm cortisol axis adequacy; low peak cortisol (<18-20 mcg/dL) supports adrenal insufficiency |
| Insulin tolerance test (ITT) | Gold standard for HPA axis and growth hormone; rarely performed due to hypoglycemia risk |
| GHRH-arginine stimulation test | Diagnose growth hormone deficiency; safer than ITT |
| CRH stimulation test | Distinguish primary from central adrenal insufficiency in equivocal cases |
| TRH stimulation | Rarely used; distinguish hypothalamic from pituitary central hypothyroidism |
Pituitary MRI
MRI of the pituitary with sellar protocol (thin slices, dynamic contrast) is the imaging study of choice:
| MRI Finding | Sheehan Pattern |
|---|---|
| Empty sella (chronic Sheehan) | CSF-filled sella with thin rim of pituitary tissue at the floor; characteristic finding in established disease |
| Partial empty sella | Less complete pituitary atrophy |
| Pituitary enlargement (acute) | In acute Sheehan, pituitary may be enlarged with infarction signs (hemorrhage, T2 hyperintensity) before progressing to atrophy |
| Posterior pituitary bright spot | Typically PRESERVED (posterior pituitary intact); contrast with pituitary apoplexy where it may be lost |
| Pituitary stalk | Usually normal or thinned; not the stalk thickening seen in lymphocytic hypophysitis |
Workup Sequence
- Initial screening: morning cortisol, TSH, free T4, prolactin, LH, FSH, estradiol, IGF-1, sodium, glucose, complete blood count
- Confirm central adrenal insufficiency: ACTH stimulation test if morning cortisol borderline
- Confirm central hypothyroidism: low/normal TSH with low free T4 essentially diagnostic; TRH stimulation rarely needed
- Confirm central hypogonadism: low LH/FSH with low estradiol in premenopausal woman
- Confirm growth hormone deficiency: low IGF-1 for age plus GHRH-arginine stimulation test
- Pituitary MRI: confirm empty sella and rule out alternative causes
- Posterior pituitary assessment: water deprivation test or copeptin only if polyuria/polydipsia symptoms (DI uncommon in Sheehan)
S4. Differential: Pituitary Apoplexy, Lymphocytic Hypophysitis, Empty Sella Syndrome
| Feature | Sheehan Syndrome | Pituitary Apoplexy | Lymphocytic Hypophysitis | Empty Sella Syndrome (primary) |
|---|---|---|---|---|
| Trigger | Postpartum hemorrhage | Pre-existing pituitary adenoma (often non-functioning macroadenoma) | Autoimmune, peripartum (lymphocytic adenohypophysitis) or post-immunotherapy | Congenital diaphragm sellae defect |
| Onset | Acute or insidious | Acute (sudden severe headache) | Subacute | Asymptomatic incidental finding usually |
| Headache | Uncommon | Severe, sudden | Possible | Uncommon |
| Visual symptoms | Uncommon (gland atrophic) | Common (chiasmal compression) | Possible if mass effect | Rare |
| Diabetes insipidus | Uncommon (<5-10%) | May occur | Common (posterior involvement) | Uncommon |
| Lactation failure | CHARACTERISTIC (lactotroph destruction) | Variable | Possible peripartum | Uncommon |
| MRI pattern | Empty sella; posterior bright spot preserved | Pituitary mass with hemorrhage/infarction | Pituitary enlargement with stalk thickening + dural enhancement | Empty sella; pituitary thin rim at floor |
| Treatment | Hormone replacement | Often surgical decompression + replacement | Glucocorticoid trial; replacement | Replacement if hormone deficiency present (often absent) |
| Hormone deficit duration | Permanent | Variable; some recovery possible | Variable; may improve with immunotherapy | None or partial; variable |
Distinguishing Features in Detail
Sheehan vs Pituitary Apoplexy
Both produce postpartum hypopituitarism but mechanism differs. Sheehan results from ischemic necrosis of normal (gestationally enlarged) pituitary; pituitary apoplexy results from hemorrhagic infarction of a pre-existing pituitary adenoma. Clinical clues: Sheehan typically presents with insidious anterior pituitary failure plus lactation failure; apoplexy presents acutely with sudden severe headache, visual loss, ophthalmoplegia, and ADH deficiency. MRI is decisive: Sheehan shows empty sella; apoplexy shows a pituitary mass with hemorrhage and infarction signs.
Sheehan vs Lymphocytic Hypophysitis
Lymphocytic hypophysitis (LyH) is autoimmune inflammation of the pituitary, occurring both peripartum (lymphocytic adenohypophysitis or panhypophysitis) and increasingly post-immune checkpoint inhibitor therapy (a recognized irAE). Pathologically distinct from Sheehan (lymphocytic infiltration not ischemic necrosis). Clinical clues: LyH may present with headache and visual symptoms more often than Sheehan, ADH deficiency more common (especially in panhypophysitis with posterior involvement), MRI shows pituitary enlargement with stalk thickening and dural enhancement rather than empty sella. May respond to glucocorticoid treatment in early disease.
Sheehan vs Primary Empty Sella Syndrome
Primary empty sella syndrome is congenital absence or defect of the diaphragm sellae allowing CSF herniation into the sella, often discovered incidentally on imaging done for other reasons. Most patients have normal pituitary function and no specific intervention required. Hormonal deficits when present are usually partial. Distinguished from Sheehan by absent obstetric history, asymptomatic discovery, and typically intact pituitary function.
S5. Lifelong Multi-Axis Hormone Replacement Strategy
Cortisol Replacement (Most Critical)
| Component | Approach |
|---|---|
| Standard regimen | Hydrocortisone 10-15 mg PO in morning + 5 mg PO in afternoon (total 15-20 mg/day; some patients need 20-25 mg total) |
| Alternative | Prednisone 2.5-5 mg PO daily (longer half-life; convenient single daily dose) |
| Stress dose for minor illness | Double the daily oral dose for fever, gastroenteritis, minor procedure |
| Stress dose for major surgery / severe illness | Hydrocortisone 100 mg IV q8h, then taper as condition improves |
| Emergency injection kit | Hydrocortisone 100 mg IM kit (Solu-Cortef) for home/travel; patient and family trained in administration |
| Patient education | MedicAlert bracelet; written stress-dose instructions; addresses gastroenteritis, fever, surgery, trauma, dental procedures |
Thyroid Replacement
| Component | Approach |
|---|---|
| Standard regimen | Levothyroxine 1.6 mcg/kg/day PO on empty stomach (30-60 min before breakfast) |
| Order of replacement | CORTISOL FIRST x 1-2 weeks, THEN start levothyroxine (prevents precipitating adrenal crisis) |
| Monitoring | Free T4 (TSH is unreliable in central hypothyroidism); target free T4 in the upper half of normal range |
| Older adults / cardiac disease | Start lower (25-50 mcg) and titrate gradually to prevent angina or arrhythmia |
Sex Hormone Replacement
| Setting | Approach |
|---|---|
| Premenopausal women | Cyclic estrogen-progesterone OR transdermal estradiol + cyclic progesterone (endometrial protection); continue until age 50-52 (natural menopause) |
| Postmenopausal women | HRT only if menopausal symptoms; otherwise no estrogen replacement |
| Fertility goals | Refer to reproductive endocrinology; gonadotropin therapy (hMG/hCG) for ovulation induction in select patients with intact ovarian function |
| Vaginal atrophy management | Local vaginal estrogen if systemic HRT inadequate or contraindicated |
| Bone density | Annual DXA; bisphosphonate consideration if osteoporosis |
Growth Hormone Replacement
| Component | Approach |
|---|---|
| Indication | Documented GH deficiency by GHRH-arginine or ITT testing PLUS symptoms (fatigue, reduced quality of life, abnormal body composition) |
| Standard regimen | Somatropin 0.2-0.5 mg SC daily at bedtime; titrate by IGF-1 to upper-normal range for age |
| Benefits | Improved body composition (reduced fat, increased lean mass), bone density, lipid profile, quality of life, exercise capacity |
| Monitoring | IGF-1 every 3-6 months; lipid panel, glucose, body composition periodically |
| Contraindications | Active malignancy; diabetic retinopathy (relative); active intracranial mass |
Sequence and Timing of Replacement
- Day 1: Initiate hydrocortisone replacement (10 mg AM + 5 mg PM, titrate by clinical response and orthostatic vital signs)
- Week 2: After stable on cortisol, start levothyroxine 1.6 mcg/kg/day (or lower if elderly/cardiac)
- Week 4-6: Free T4 at 4-6 weeks; adjust levothyroxine to achieve upper-normal free T4
- Month 1-2: Add sex hormone replacement (estrogen-progesterone in premenopausal)
- Month 3-6: Evaluate growth hormone axis with GHRH-arginine stimulation; initiate somatropin if confirmed deficient
- Ongoing: Patient education, MedicAlert, emergency kit, stress-dose instructions, family training
Patient Education and Lifelong Care
| Education Topic | Key Points |
|---|---|
| Stress-dose steroids | Double oral hydrocortisone for fever, gastroenteritis, minor procedures; IV hydrocortisone 100 mg for severe illness or surgery; never miss a dose during illness |
| Emergency injection kit | Hydrocortisone 100 mg IM kit at home and during travel; family member trained to administer if patient unable |
| MedicAlert identification | Bracelet or wallet card identifying adrenal insufficiency for emergency responders |
| Sick day rules | Written instructions; cannot tolerate oral steroids? Use IM hydrocortisone and seek immediate medical care |
| Surgery / dental procedures | Pre-procedural stress-dose coverage; inform anesthesia/dentist |
| Fertility counseling | Pregnancy possible with gonadotropin therapy; stress-dose coverage during pregnancy and delivery; preconception planning |
| Bone health | Annual DXA; calcium, vitamin D supplementation; weight-bearing exercise |
| Cardiovascular health | Lipid management, blood pressure monitoring; address metabolic syndrome features |
| Mental health | Screen for depression; counseling support |
S6. Practice Insights — Lessons from the Endocrinology Clinic
1. Obstetric hemorrhage + lactation failure = mandatory pituitary workup
The single highest-yield rule in experienced practice is that any postpartum mother who experienced significant obstetric hemorrhage (transfusion required, hypotension, DIC, severe preeclampsia/HELLP) and cannot initiate or maintain lactation despite intent deserves anterior pituitary hormone testing within weeks of delivery, not deferred to later workup of nonspecific fatigue. Catching Sheehan at the lactation-failure stage allows initiation of replacement therapy before the morbid late deficits accumulate. clinicians have made this the standard postpartum follow-up question in experienced practice for high-risk obstetric histories.
2. Cortisol replacement BEFORE levothyroxine, always
The most preventable iatrogenic complication in clinical experience is precipitating adrenal crisis by initiating levothyroxine in a patient with unrecognized central adrenal insufficiency. Experienced practice is to ALWAYS check morning cortisol (and ACTH stim if borderline) before any thyroid replacement in suspected hypopituitarism, and to initiate hydrocortisone replacement for 1-2 weeks before adding levothyroxine. The accelerated cortisol metabolism induced by thyroid hormone can convert subclinical adrenal insufficiency into acute crisis within days of levothyroxine initiation.
3. Stress-dose education at every visit, not just at diagnosis
In experienced hands, the patients who avoid adrenal crisis are those whose stress-dose education is reinforced at every endocrinology visit, who carry MedicAlert identification, and who have hydrocortisone emergency injection kits at home with family training. Patients forget instructions over years; reinforcement at each visit ensures the safety net remains functional. Experienced clinicians review the written sick day rules, demonstrate the emergency injection, and confirm the patient and at least one family member can administer it. This 5-minute exercise at each visit has prevented countless preventable crises.
4. Take the decades-old obstetric history seriously in older women
Many Sheehan patients in experienced practice present in their 50s-70s with fatigue, hyponatremia, hypotension, or unexplained hypothyroidism that proves to be Sheehan from an obstetric hemorrhage 20-40 years previously. The obstetric history is often not volunteered because patients do not connect the long-ago event to current symptoms. Experienced practice asks every woman with suspected hypopituitarism about all prior pregnancies, including transfusion requirement, postpartum complications, and lactation history. The decades-old hemorrhage can be the decisive diagnostic clue.
Personal protocol adjustments beyond the published guideline
- Anterior pituitary panel within weeks of postpartum hemorrhage with lactation failure. The guideline supports evaluation when symptoms develop; experienced practice initiates structured pituitary hormone testing in any postpartum mother with significant hemorrhage history and lactation failure, not waiting for additional symptoms to develop.
- Cortisol replacement ALWAYS before levothyroxine in suspected hypopituitarism. The guideline implies this sequence; experienced practice formalizes it as a non-negotiable rule with explicit checklists for trainees to prevent iatrogenic adrenal crisis from thyroid hormone initiation in unrecognized central adrenal insufficiency.
- Stress-dose education reinforced at every visit with emergency kit demonstration. The guideline supports patient education; experienced practice requires 5-minute review at every visit of sick day rules, MedicAlert identification, and emergency injection kit use with family member demonstration.
- Decades-old obstetric history actively elicited in any woman with hypopituitarism workup. The guideline considers history-taking; experienced practice formalizes specific questions about all prior pregnancies, hemorrhage, transfusion, postpartum complications, and lactation history in any woman with possible hypopituitarism regardless of current age.
Four-panel personal framework: the pituitary anatomy showing why anterior pituitary is vulnerable to ischemia while posterior pituitary is preserved (panel 1), the hormone deficit cascade timeline from earliest prolactin loss to latest ACTH loss decades later (panel 2), the central versus primary hypothyroidism distinction emphasizing the TSH-only screening pitfall (panel 3), and the four-step replacement therapy sequence with cortisol-before-thyroid rule as the safety priority (panel 4). Approximate ranges; not institutional outcome data.
S7. Frequently Asked Questions
- Hypopituitarism: Diagnosis, Hormone Replacement, and Long-Term Management
- Tirzepatide: GIP/GLP-1 Dual Agonist for Diabetes and Obesity
- Pituitary Incidentaloma: Workup, Surveillance, and Management
- Thyroid Nodule Evaluation: TI-RADS, FNA, and Bethesda Classification
- Amenorrhea Workup: Primary, Secondary, Hypothalamic, PCOS, and Premature Ovarian Insufficiency
- Pituitary Apoplexy: Diagnosis and Emergency Management